Bain Capital, LP is one of the world’s leading private investment firms with approximately $185 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact ir@baincapital.com.

Matthew Calistri

Matthew Calistri

Managing Director
Life Sciences
Boston

Experience

Matt Calistri joined Bain Capital in 2024. He is a Managing Director in the Portfolio Group for the Life Sciences business.

Prior to joining Bain Capital, Matt spent four years at Cerevel Therapeutics in several key roles including Vice President of Investor Relations and Vice President of Corporate Strategy. He was an integral part of the team that took Cerevel public and raised over $2 billion in capital before Cerevel was acquired by AbbVie for $8.7 billion. Previously, Matt was Vice President of Investor Relations at Sage and Vice President of Investor Relations at Biogen where he initially started in Corporate Strategy. Before pivoting to the biopharma industry, Matt held leadership roles in financial services, most notably at Gerson Lehrman Group (GLG), where he grew revenues, opened and managed the Boston office, and ran the North America Financial Services Practice. Matt has also held roles at ITG, UBS, Bankers Trust, and E&Y.


Education

Matt received an MBA in finance from The University of Chicago Booth School of Business and a BS in accounting from Fordham University Gabelli School of Business.